Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.400 -0.160 (-3.51%)
Streaming Delayed Price Updated: 1:10 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
After the market close on Wednesday, Recursion said it intends to offer and sell $200 million worth of its common stock in an underwritten public offering. All of the shares are being offered by... 
Via Benzinga
Recursion Announces Proposed Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
How Is The Market Feeling About Recursion Pharmaceuticals?
Via Benzinga
Recursion Pharm Stock Sees Relative Strength Rating Rise To 84
On Tuesday, Recursion Pharm stock had its Relative Strength (RS) Rating upgraded to 84, up from 78 a day earlier. 
Via Investor's Business Daily
Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening?
Shares of clinical stage biotech company Recursion Pharmaceuticals Inc (NASDAQ:RXRX) are trading higher Tuesday. The company's CEO Chris Gibson joined CNBC for an interview ahead of a presentation with... 
Via Benzinga
What's Going On With Recursion Pharmaceuticals Stock Monday?
Recursion Pharmaceuticals shares traded higher Monday after the company provided updated guidance and partnership updates at its Investor Day. The stock is continuing to move higher after hours amid a... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... 
Via Talk Markets
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
The global 
Via Talk Markets
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst. 
Via InvestorPlace
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
The global 
Via Talk Markets
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
The CEO has set a high bar for the business, and if it hits it, the stock could easily 10x in value. 
Via The Motley Fool
Nvidia’s Golden Handshake: 3 Stocks Reaping the Rewards of an NVDA Alliance
These Nvidia partner stocks stand to gain from the semiconductor's industry dominance, but they have plenty of upside of their own. 
Via InvestorPlace
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
Both of these companies could soon set the standard in their fields. 
Via The Motley Fool
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Cathie Wood Owns These 2 AI Stocks. Should You?
One looks like a solid option. The other one, not so much. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
Recursion Pharmaceuticals hopes to transform the healthcare industry with the help of AI. 
Via The Motley Fool
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
Published open-access today in Nature Genetics, “High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing” identifies novel evidence of a proximity bias in... 
From Recursion Pharmaceuticals
Via GlobeNewswire
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
You don't need to buy her picks, but it's worth understanding them. 
Via The Motley Fool
Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
This article highlights the performances last week and MTD of the 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies along with their areas of focus in our... 
Via Talk Markets
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
Dr. Hershberg is a current board member with over 25 years of experience as a physician, scientist, and entrepreneur 
From Recursion Pharmaceuticals
Via GlobeNewswire
2 Stocks That Could 10x by 2035
These stocks are very promising, but it's important to consider the downside, too. 
Via The Motley Fool
Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
Jim Cramer says Corning has "not been able to generate the kind of return that I've wanted"; calls Recursion a "terrific spec" 
Via Benzinga
A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
The drug development process is very expensive and time-consuming which creates a huge shortage in drug candidates and programs but the advent of AI can significantly shorten and cheapen this process... 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's the Difference Between Biotech Stocks and TechBio Stocks?
A few enterprising businesses are marketing themselves differently. 
Via The Motley Fool
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.